- Sputnik Africa, 1920
Global South Pole
Global South Pole is more than just a podcast. It’s a platform dedicated to challenging the mainstream narratives and amplifying the voices of the overlooked communities. It’s time to rewrite the maps to plant the Global South at the center.

Africa’s Biological Wealth Must Translate Into African Value, Health Expert Says

Africa’s Biological Wealth Must Translate Into African Value, Health Expert Says
Subscribe
As global attention turns toward health systems and scientific innovation, Africa’s vast biological and genetic diversity is increasingly seen as a critical asset. Experts are now highlighting the importance of ensuring that this wealth not only contributes to global knowledge, but also delivers tangible benefits for the continent itself.
This conversation is gaining momentum as African countries expand their capacity in genomics, vaccine development, and biomedical research. While scientific progress continues to advance, questions around ownership, governance, and long-term value remain central. At the heart of the discussion is how Africa can position itself not just as a contributor, but as a key beneficiary in global health systems.
Global South Pole engaged Dr. Taime Sylvester, Senior Lecturer of Clinical Health Sciences at Namibia University of Science and Technology.
Dr. Sylvester highlights that Africa’s unparalleled genetic diversity positions it at the center of global scientific discovery, but stressed that the real shift lies in strengthening governance systems that ensure research, data, and resulting innovations are increasingly controlled, led, and retained within the continent.

"Africa only generates about 20% of global genomic data. The raw biological wealth is here; the sequencing, analysis, publications, patents, the commercial products—those largely happen elsewhere. That is the core sovereignty deficit. Africa provides the material, and the world captures the value. [...] If you think about CRISPR-based gene therapies for sickle cell disease [...] These therapies were developed using genomic research to which African populations were central. They're priced at more than $2.2 million, but Africans have zero access. That is what the biological sovereignty deficit looks like. African biology, foreign profits. African patients are unable to benefit from discoveries made from their own genetic heritage. And I want to acknowledge that there are some countries that are beginning to assert themselves because it really matters. In Nigeria, there's the 100,000 Genome Project. South Africa has 110,000 human genomes initiatives. [...] These are serious scientific investments in building African-controlled genomic data infrastructure, and they represent a genuine shift in ambition," Dr. Sylvester stressed.

To listen to the whole discussion, tune in to the Global South Pole podcast, brought to you by Sputnik Africa.
In addition to the website, you can also catch our episodes on Telegram.
You can also listen to our podcast on Apple Podcasts, Spotify, Deezer, Castbox, Pocket Casts, Afripods, Podcast Addict, Overcast, and Mave Stream.
Check out all the episodes of Global South Pole
Newsfeed
0